Glaxo Could Face $6bn Avandia Liability, Says UBS

March 5, 2010

Related

Fujifilm Biotechnologies to leverage downstream purification system at UK site

Fujifilm Biotechnologies to leverage downstream purification system at UK site

Fujifilm’s modular, scalable manufacturing takes shape amid complex global supply chain

Fujifilm’s modular, scalable manufacturing takes shape amid complex global supply chain

2026 Manufacturing Pharma Trends for Life Sciences

Sponsored

2026 Manufacturing Pharma Trends for Life Sciences

2026 AI Trends in Life Sciences

Sponsored

2026 AI Trends in Life Sciences

Trending

Siegfried expands US manufacturing footprint with acquisition of two facilities

Lilly to invest $3.5B in injectable drug, device manufacturing facility in Pennsylvania

Catalent to close cell therapy center in Belgium amid reported drop in production

Sponsored Picks

Sponsored

Life Sciences Manufacturing Software Buyers Guide

Sponsored

AI-Powered QMS: The Future of Quality Management

Sponsored

2026 AI Trends in Life Sciences